Novel therapeutic approaches targeting intracellular trafficking of RTK mutants in acute myeloid leukemia cells.
Project/Area Number |
25461439
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Kinki University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
MATSUMURA Itaru 近畿大学, 医学部, 教授 (00294083)
HIRASE Chikara 近畿大学, 医学部, 医学部講師 (30548590)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 白血病 / 受容体 / 細胞内輸送 / 分子標的 / 膜輸送 / 造血因子 |
Outline of Final Research Achievements |
FLT3-ITD and KIT D816V mutation are frequently found in AML and associated with poor prognosis. In this study, we evaluated the anti-leukemic effects of an inhibitor of membrane trafficking, chlorpromazine (CPZ). Recent studies demonstrated that these oncogenic RTKs are mislocalized in the cytoplasm, where they transmit aberrant signals to downstream. CPZ disrupted the intracellular trafficking of RTK mutants, and significantly suppressed activities of RTK mutants and their downstream molecules. Consequently, CPZ inhibited the growth and survival of AML cells with mutant RTK in a dose-dependent manner. In xenotransplantation models, administration of CPZ significantly reduced engraftment of AML cells, and also showed the cytotoxic effect to AML stem cells, while displaying minimal toxicity to normal hematopoietic cells. These results suggest that CPZ would be a promising therapeutic drug to eradicate AML cells with an established safety profile.
|
Report
(4 results)
Research Products
(48 results)
-
[Journal Article] ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.2016
Author(s)
Ishibashi T, Yokota T, Tanaka H, Ichii M, Sudo T, Satoh Y, Doi Y, Ueda T, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
-
Journal Title
Experimental Hematology
Volume: 44
Issue: 4
Pages: 269-281
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
[Journal Article] The preventative effects of recombinant thrombomodulin on transplantation- associated coagulopathy after allogeneic hematopoietic stem cell transplantation2014
Author(s)
Nomura S, Ishii K, Maeda Y, Katayama Y, Yagi H, Fujishima N, Ota S, Seki M, Okada M, Ikezoe T, Hayashi K, Fujita S, Satake A, Ito T, Kyo T, Ishida Y, Chiba S, Ogawa H, Tanimoto M, Sawada K
-
Journal Title
Journal of Stem Cell Research & Therapy
Volume: 4
Issue: 1
Pages: 247-247
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Clathrin assembly protein CALM Plays a Critical Role in KIT Signaling by Regulating Its Cellular Transport from Early to Late Endosomes in Hematopoietic Cells.2014
Author(s)
Shinya Rai, Hirokazu Tanaka*, Mai Suzuki , Honami Ogoh, Yasuhiro Taniguchi, Yasuyoshi Morita, Takahiro Shimada, Akira Tanimura, Keiko Matsui, Takafumi Yokota, Kenji Oritani, Kenji Tanabe, Toshio Watanabe, Yuzuru Kanakura, and Itaru Matsumura
-
Journal Title
PLoS ONE
Volume: 該当しない
Issue: 10
Pages: 0109441-0109441
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents.2014
Author(s)
Kuroda J, Shimura Y, Ohta K, Tanaka H, Shibayama H, Kosugi S, Fuchida S, Kobayashi M, Kaneko H, Uoshima N, Ishii K, Nomura S, Taniwaki M, Takaori-Kondo A, Shimazaki C, Tsudo M, Hino M, Matsumura I, Kanakura Y; Kansai Myeloma Forum Investigators.
-
Journal Title
Int J Hematol.
Volume: 99
Issue: 4
Pages: 441-449
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] The anti-apoptotic gene Anamorsin is essential for both autonomous and extrinsic regulation of murine fetal liver hematopoiesis.2014
Author(s)
Tanimura A, Shibayama H, Hamanaka Y, Fujita N, Ishibashi T, Sudo T, Yokota T, Ezoe S, Tanaka H, Matsumura I, Oritani K, Kanakura Y.
-
Journal Title
Exp Hematol.
Volume: 42
Issue: 5
Pages: 410-422
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients2014
Author(s)
Sakurai M, Kunimoto H, Watanabe N, Fukuchi Y, Yuasa S, Yamazaki S, Nishimura T, Sadahira K, Fukuda K, Okano H, Nakauchi H, Morita Y, Matsumura I, Kudo K, Ito E, Ebihara Y, Tsuji K, Harada Y, Harada H, Okamoto S, Nakajima H
-
Journal Title
Leukemia
Volume: 28
Issue: 12
Pages: 2344-54
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
[Journal Article] The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages.2013
Author(s)
Satoh Y, Yokota T, Sudo T, Kondo M, Lai A, Kincade PW, Kouro T, Iida R, Kokame K, Miyata T, Habuchi Y, Matsui K, Tanaka H, Matsumura I, Oritani K, Kohwi-Shigematsu T, Kanakura Y.
-
Journal Title
Immunity
Volume: 38
Issue: 6
Pages: 1105-1115
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Analysis of conditioning regimen for ASCT with relapsed or refractory malignant lymphoma2014
Author(s)
Kentaro Serizawa,Yasuyoshi Morita,Takahide Taniguchi,Yasuyo Oyama,Masaya Kawauchi,Takahiro Kumode,Yoshitaka kanai,Shikara Hirase,Hirokazu Tanaka,Jyunichi Miyatake,Youichi Tatsumi,Takashi Ashisda,Itaru Matsumura
Organizer
第76回日本血液学会学術集会
Place of Presentation
大阪・大阪国際会議場
Year and Date
2014-10-31 – 2014-11-02
Related Report
-
[Presentation] A case of Mogamulizunab tertment for refractory ATLL to DLI following allo-SCT2014
Author(s)
Takahide Taniguchi,kentaro Serizawa,Yasuyoshi Morita,Yasuyo Oyama,Masaya Kaawauchi,Takahiro Kumode,Yoshitaka Kanai,Chikara Hirase,Hirokazu Tanaka,Jyunichi Miyatake,Youichi Tatsumi,Takashi Ashida,Itaru Matsumura
Organizer
第76回日本血液学会学術集会
Place of Presentation
大阪・大阪国際会議場
Year and Date
2014-10-31 – 2014-11-02
Related Report
-
[Presentation] ISS is a predictive factor of SCT effect for symptomatic myeloma patients under age 652014
Author(s)
Hitomi Kaneko,Eiji Nakatani,Hirohiko Shibayama,Takae Kohara,Masayuki Kobayashi,Kazue Miyamoto,Maki Shindo,Shin-Ichi Fuchida,Hirokazu Tanaka,Junya Kuroda,Hideo Yagi,Satoru Kosugi,Toru Kida,Nobuhiko Uoshima,Yayoi Matsumura,Yuri Kamitsuji,Yoko Adachi,Kensuke Ohta,Kazuyoshi Ishii,Itaru Matsumura,Yuzuru Kanakura,et al.
Organizer
第76回日本血液学会学術集会
Place of Presentation
大阪・大阪国際会議場
Year and Date
2014-10-31 – 2014-11-02
Related Report
-
[Presentation] The effects of consolisation and maintenance therapies for symptomatic MM patients after auto HSCT2014
Author(s)
Hirohiko Shibayama,Eiji Nakatani Junya Kuroda,Shin-IchiFuchida,Hitomi kaneko,kensuke Ohta,Katae Kohara,Satoru kosugi,Yoko Adachi,Hideo Yagi,Masayuki Kobayashi,Kazue Miyamoto,Hirokazu Tanaka,Nobuhiko Uoshima,Toru Kida,Kazuyoshi Ishii,Yuri Kamitsuji,Tsuneyoshi Hamada,Itaru Matsumura,Yuzuru Kanakura,et al.
Organizer
第76回日本血液学会学術集会
Place of Presentation
大阪・大阪国際会議場
Year and Date
2014-10-31 – 2014-11-02
Related Report
-
[Presentation] Leukemogenic FLT3-ITD and KIT D814V depend more in CALM function than their wild types to transmit growth/survival signals:Identification of CALM as a new therapeutic target2014
Author(s)
Shinya Rai,Hirokazu Tanaka,Yasuhiro Taniguchi,Takahiro Shimada,Mai Suzuki,Akira Tanimura,Keiko Matsui,Toshio Watanabe,,Yuzuru Kanakura,Itaru Matsumura
Organizer
第19回欧州血液学会
Place of Presentation
Italy・Milano
Year and Date
2014-06-12 – 2014-06-15
Related Report
-
-
[Presentation] Retrospective analysis of 434 symptomatic myeloma cases registered in Kansai Myeloma Forum.2013
Author(s)
Shibayama H, Ohta K, Tanaka H, Kohara T, Kosugi S, Kido T, Fuchida S, Miyamoto K, Shindo M, Kobayashi M, Hamada T, Nakatani E, Tudo M, Shimazaki C, Takaori A, Taniwaki M, Nomura S, Matsumura I, Kanakura Y, et al
Organizer
第75回日本血液学会学術集会
Place of Presentation
ロイトン札幌・さっぽろ芸文館・札幌市教育文化会館
Related Report
-
[Presentation] Results of gemcitabine therapy for relapsed of refractory Non-Hodgkin's lymphoma in one institute.2013
Author(s)
Serizawa K, Morita Y, Taniguchi Y, Kawauchi M, Eguchi G, Emoto M, Kanai Y, Rai S, Hirase C, Tanaka H, Shimada T, Tatsumi Y, Ashida T, Matsumura I.
Organizer
第75回日本血液学会学術集会
Place of Presentation
ロイトン札幌・さっぽろ芸文館・札幌市教育文化会館
Related Report
-
[Presentation] Trib1 and Trib2 block myeloid differentiation by suppressing AKT phosphorylation.2013
Author(s)
Kanai Y, Shimada T, Taniguchi Y, Rai S, Hirase C, Morita Y, Tanaka H, Miyatake J, Tatsumi Y, Ashida T, Matsumura I.
Organizer
第75回日本血液学会学術集会
Place of Presentation
ロイトン札幌・さっぽろ芸文館・札幌市教育文化会館
Related Report
-
-
-
-
-
-
-
-
-
-